hVIVO (LON:HVO) Shares Pass Above 50-Day Moving Average – Should You Sell?

hVIVO plc (LON:HVO) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 6.86 and traded as high as GBX 7.10. hVIVO shares last traded at GBX 7.03, with a volume of 575,324 shares changing hands.

hVIVO Stock Down 2.6%

The company has a 50-day simple moving average of GBX 6.85 and a 200 day simple moving average of GBX 7.54. The company has a market cap of £46.26 million, a P/E ratio of -7.72 and a beta of 1.71. The company has a current ratio of 1.63, a quick ratio of 1.16 and a debt-to-equity ratio of 38.75.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers.